Road to recovery: What COVID-19 means for medtech in China and around the world

Posted by Tim Lee on May 4, 2020

Access COVID-19 resources

Given the increasing toll that COVID-19 lockdowns are imposing on economies, many markets that have seen their peaks are beginning preparations to reopen. As the first market impacted by COVID-19 and the first to institute a gradual reopening since March, China is two months ahead of all other major markets in their recovery journey. We spoke to several medtech executives across different spaces to get a glimpse of what the future may look like in China, as well what it may mean for other markets.


>
Read More

Finding Purpose: The Role of the Sales Force During COVID-19

Posted by Chris Morgan on April 9, 2020

Emily Alexander and Jason Brown co-wrote this blog post with Chris Morgan. 

Access COVID-19 resources

The most pressing challenge for our society is the impact the COVID-19 pandemic is having on the global population and economy. Protecting the health of the population is the chief priority, and stabilizing the economy is the next most urgent. However, as medtech companies navigate this challenging landscape, leadership also is grappling with how to keep their sales teams engaged and productive. Medtech companies are rapidly addressing practical issues like incentives, targets and rewards and are accelerating initiatives in digital communication and virtual learning.


>
Read More

Why the Growth of Outpatient Centers Should Remain Top of Mind

Posted by Brian Chapman on March 11, 2020

Two months ago, I thought it was the healthcare story of the year: A huge number of procedures are receiving authorization to be conducted outside of the hospital. However, that’s starting to pale in comparison to the news of the moment, COVID-19, which is going to silence much of our talk over the next three-plus months. But I maintain that when the (hopefully figurative) dust clears, 2020 will be the tipping point—the year that many routine procedures move outside of the hospital.


>
Read More

Alternate Sites of Care: The Changing Face of Healthcare Delivery

Posted by Parijat Sharma on December 23, 2019

Matthew Ruple co-authored this post with Parijat Sharma. A version of this blog post was originally published on The Active Ingredient.

A confluence of factors is driving a dramatic shift in healthcare delivery from traditional sites of care such as hospitals and clinics to outpatient and retail care sites such as urgent care clinics and ambulatory surgical centers. Of course, this shift doesn’t just change things for patients and providers. It also greatly affects the go-to-market strategies for pharmaceutical and medical device manufacturers. As the care setting evolves and diversifies, stakeholders throughout the healthcare ecosystem have to evolve in kind.


>
Read More

The Future Is Now: How Analytics Can Solve Today’s Business Problems

Posted by Indraneel Mukherjee on December 5, 2019

“2020 will be an exciting year for us. We’ll launch a few advanced devices and solutions that will have a transformative impact on patient lives and will position us as the leading provider of care in our therapeutic area,” said a general manager of a large capital equipment manufacturer.


>
Read More